Press-release for stocks for VTRS

Prices are updated after-hours

Theravance Biopharma, Inc. Announces Strategic Actions to Focus on Respiratory Disease Portfolio
Published: 2021-09-15 (Crawled : 12:00) - biospace.com/
VTRS | News A | $11.42 0.53% 1.7M

| -16.96% | O: -0.44% H: 1.17% C: 0.81%
TBPH | $9.225 0.05% 88K

| 14.68% | O: -19.15% H: 15.54% C: 4.15%
INVA | $15.215 0.3% 160K

| 0.6% | O: 0.2% H: 0.4% C: -0.53%
disease biopharma respiratory

58%

42%

CZOO | $10.52 110.82% 10M

CSSE 4 | $0.3181 108.86% 170M

BOF | $1.88 60.68% 98M

AMST | $3.1 55.0% 66M

LICN | $0.85 51.79% 13M

WIMI | $1.03 41.99% 15M

SKIL 4 | $8.045 40.89% 230K

MULN | News | $3.805 39.38% 11M

RILY | $30.01 38.17% 11M

MTC | $3.04 35.71% 6.7M

Save your searches and get alerts when important news are released.